Tussicaps

Catarrh, Migraine, Coughing + 55 more
Treatment
6 FDA approvals
20 Active Studies for Tussicaps

What is Tussicaps

ChlorpheniramineThe Generic name of this drug
Treatment SummaryHydrocodone is a powerful painkiller that is usually taken in combination with acetaminophen to treat moderate to severe pain. It used to be used as a cough suppressant but has since been replaced by dextromethorphan in cough and cold medicines. Hydrocodone’s more potent metabolite, hydromorphone, is sometimes prescribed for severe pain. Hydrocodone was first approved for use by the FDA in 1943 as part of the cough suppressant syrup Hycodan.
Rynatussis the brand name
Tussicaps Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Rynatuss
Chlorpheniramine
1960
47

Approved as Treatment by the FDA

Chlorpheniramine, also known as Rynatuss, is approved by the FDA for 6 uses including Acute Bronchitis and Allergic Rhinitis (AR) .
Acute Bronchitis
Used to treat Cough in combination with Hydrocodone
Allergic Rhinitis (AR)
Cold
Used to treat Cold in combination with Hydrocodone
Allergy to Tree Pollen
upper respiratory symptoms
Used to treat upper respiratory symptoms in combination with Hydrocodone
Hypersensitivity
Used to treat Allergic Reaction in combination with Hydrocodone

Effectiveness

How Tussicaps Affects PatientsHydrocodone is a painkiller that works by blocking pain signals from reaching the brain. It also produces feelings of euphoria, slowed breathing, and drowsiness.
How Tussicaps works in the bodyHydrocodone works by targeting two kinds of opioid receptors in the body: mu and delta. It binds to these receptors, stopping nerve signals that would normally lead to pain. It also affects the brain's reward system, producing a feeling of pleasure. Hydrocodone also has an inhibitory effect on GABAergic neurons in the ventral tegmental area, leading to sedation and respiratory depression. The effects of delta opioid receptors are not as well studied but may also contribute to pain relief.

When to interrupt dosage

The recommended measure of Tussicaps is contingent upon the determined illness, including Coughing, Coughing and Chronic Pain. The exact amount of dosage is dependent upon the method of administration (e.g. Tablet, extended release - Oral or Tablet - Oral) featured in the table below.
Condition
Dosage
Administration
Migraine
, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL
, Liquid - Oral, Oral, Tablet, Liquid, Solution - Oral, Tablet - Oral, Syrup - Oral, Syrup, Tablet, coated, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Granule, effervescent - Oral, Powder, for solution, Capsule, liquid filled, Granule, effervescent, Capsule, liquid filled - Oral, Capsule, Capsule - Oral, Solution, Tablet, extended release - Oral, Tablet, extended release, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, for solution - Oral, Kit, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Lozenge - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Powder, Powder - Oral, Liquid; Tablet - Oral; Parenteral, Liquid; Tablet, Oral; Parenteral, Intramuscular; Intravenous; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet, Kit; Tablet - Oral, Kit; Powder, Kit; Powder - Oral, Topical, Liquid - Topical, Kit; Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Kit - Oral, Kit; Powder, for solution, Solution / drops, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets
Coughing
, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL
, Liquid - Oral, Oral, Tablet, Liquid, Solution - Oral, Tablet - Oral, Syrup - Oral, Syrup, Tablet, coated, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Granule, effervescent - Oral, Powder, for solution, Capsule, liquid filled, Granule, effervescent, Capsule, liquid filled - Oral, Capsule, Capsule - Oral, Solution, Tablet, extended release - Oral, Tablet, extended release, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, for solution - Oral, Kit, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Lozenge - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Powder, Powder - Oral, Liquid; Tablet - Oral; Parenteral, Liquid; Tablet, Oral; Parenteral, Intramuscular; Intravenous; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet, Kit; Tablet - Oral, Kit; Powder, Kit; Powder - Oral, Topical, Liquid - Topical, Kit; Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Kit - Oral, Kit; Powder, for solution, Solution / drops, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets
Allergy to vaccine
, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL
, Liquid - Oral, Oral, Tablet, Liquid, Solution - Oral, Tablet - Oral, Syrup - Oral, Syrup, Tablet, coated, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Granule, effervescent - Oral, Powder, for solution, Capsule, liquid filled, Granule, effervescent, Capsule, liquid filled - Oral, Capsule, Capsule - Oral, Solution, Tablet, extended release - Oral, Tablet, extended release, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, for solution - Oral, Kit, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Lozenge - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Powder, Powder - Oral, Liquid; Tablet - Oral; Parenteral, Liquid; Tablet, Oral; Parenteral, Intramuscular; Intravenous; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet, Kit; Tablet - Oral, Kit; Powder, Kit; Powder - Oral, Topical, Liquid - Topical, Kit; Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Kit - Oral, Kit; Powder, for solution, Solution / drops, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets
Sneezing
, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL
, Liquid - Oral, Oral, Tablet, Liquid, Solution - Oral, Tablet - Oral, Syrup - Oral, Syrup, Tablet, coated, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Granule, effervescent - Oral, Powder, for solution, Capsule, liquid filled, Granule, effervescent, Capsule, liquid filled - Oral, Capsule, Capsule - Oral, Solution, Tablet, extended release - Oral, Tablet, extended release, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, for solution - Oral, Kit, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Lozenge - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Powder, Powder - Oral, Liquid; Tablet - Oral; Parenteral, Liquid; Tablet, Oral; Parenteral, Intramuscular; Intravenous; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet, Kit; Tablet - Oral, Kit; Powder, Kit; Powder - Oral, Topical, Liquid - Topical, Kit; Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Kit - Oral, Kit; Powder, for solution, Solution / drops, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets
Hives
, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL
, Liquid - Oral, Oral, Tablet, Liquid, Solution - Oral, Tablet - Oral, Syrup - Oral, Syrup, Tablet, coated, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Granule, effervescent - Oral, Powder, for solution, Capsule, liquid filled, Granule, effervescent, Capsule, liquid filled - Oral, Capsule, Capsule - Oral, Solution, Tablet, extended release - Oral, Tablet, extended release, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, for solution - Oral, Kit, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Lozenge - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Powder, Powder - Oral, Liquid; Tablet - Oral; Parenteral, Liquid; Tablet, Oral; Parenteral, Intramuscular; Intravenous; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet, Kit; Tablet - Oral, Kit; Powder, Kit; Powder - Oral, Topical, Liquid - Topical, Kit; Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Kit - Oral, Kit; Powder, for solution, Solution / drops, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets
Acute Bronchitis
, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL
, Liquid - Oral, Oral, Tablet, Liquid, Solution - Oral, Tablet - Oral, Syrup - Oral, Syrup, Tablet, coated, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Granule, effervescent - Oral, Powder, for solution, Capsule, liquid filled, Granule, effervescent, Capsule, liquid filled - Oral, Capsule, Capsule - Oral, Solution, Tablet, extended release - Oral, Tablet, extended release, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, for solution - Oral, Kit, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Lozenge - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Powder, Powder - Oral, Liquid; Tablet - Oral; Parenteral, Liquid; Tablet, Oral; Parenteral, Intramuscular; Intravenous; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet, Kit; Tablet - Oral, Kit; Powder, Kit; Powder - Oral, Topical, Liquid - Topical, Kit; Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Kit - Oral, Kit; Powder, for solution, Solution / drops, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets
Acute Bronchitis
, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL
, Liquid - Oral, Oral, Tablet, Liquid, Solution - Oral, Tablet - Oral, Syrup - Oral, Syrup, Tablet, coated, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Granule, effervescent - Oral, Powder, for solution, Capsule, liquid filled, Granule, effervescent, Capsule, liquid filled - Oral, Capsule, Capsule - Oral, Solution, Tablet, extended release - Oral, Tablet, extended release, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, for solution - Oral, Kit, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Lozenge - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Powder, Powder - Oral, Liquid; Tablet - Oral; Parenteral, Liquid; Tablet, Oral; Parenteral, Intramuscular; Intravenous; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet, Kit; Tablet - Oral, Kit; Powder, Kit; Powder - Oral, Topical, Liquid - Topical, Kit; Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Kit - Oral, Kit; Powder, for solution, Solution / drops, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets
upper respiratory symptoms
, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL
, Liquid - Oral, Oral, Tablet, Liquid, Solution - Oral, Tablet - Oral, Syrup - Oral, Syrup, Tablet, coated, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Granule, effervescent - Oral, Powder, for solution, Capsule, liquid filled, Granule, effervescent, Capsule, liquid filled - Oral, Capsule, Capsule - Oral, Solution, Tablet, extended release - Oral, Tablet, extended release, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, for solution - Oral, Kit, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Lozenge - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Powder, Powder - Oral, Liquid; Tablet - Oral; Parenteral, Liquid; Tablet, Oral; Parenteral, Intramuscular; Intravenous; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet, Kit; Tablet - Oral, Kit; Powder, Kit; Powder - Oral, Topical, Liquid - Topical, Kit; Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Kit - Oral, Kit; Powder, for solution, Solution / drops, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets
Upper respiratory tract congestion
, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL
, Liquid - Oral, Oral, Tablet, Liquid, Solution - Oral, Tablet - Oral, Syrup - Oral, Syrup, Tablet, coated, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Granule, effervescent - Oral, Powder, for solution, Capsule, liquid filled, Granule, effervescent, Capsule, liquid filled - Oral, Capsule, Capsule - Oral, Solution, Tablet, extended release - Oral, Tablet, extended release, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, for solution - Oral, Kit, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Lozenge - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Powder, Powder - Oral, Liquid; Tablet - Oral; Parenteral, Liquid; Tablet, Oral; Parenteral, Intramuscular; Intravenous; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet, Kit; Tablet - Oral, Kit; Powder, Kit; Powder - Oral, Topical, Liquid - Topical, Kit; Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Kit - Oral, Kit; Powder, for solution, Solution / drops, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets
Itching
, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL
, Liquid - Oral, Oral, Tablet, Liquid, Solution - Oral, Tablet - Oral, Syrup - Oral, Syrup, Tablet, coated, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Granule, effervescent - Oral, Powder, for solution, Capsule, liquid filled, Granule, effervescent, Capsule, liquid filled - Oral, Capsule, Capsule - Oral, Solution, Tablet, extended release - Oral, Tablet, extended release, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, for solution - Oral, Kit, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Lozenge - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Powder, Powder - Oral, Liquid; Tablet - Oral; Parenteral, Liquid; Tablet, Oral; Parenteral, Intramuscular; Intravenous; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet, Kit; Tablet - Oral, Kit; Powder, Kit; Powder - Oral, Topical, Liquid - Topical, Kit; Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Kit - Oral, Kit; Powder, for solution, Solution / drops, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets
Conjunctivitis
, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL
, Liquid - Oral, Oral, Tablet, Liquid, Solution - Oral, Tablet - Oral, Syrup - Oral, Syrup, Tablet, coated, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Granule, effervescent - Oral, Powder, for solution, Capsule, liquid filled, Granule, effervescent, Capsule, liquid filled - Oral, Capsule, Capsule - Oral, Solution, Tablet, extended release - Oral, Tablet, extended release, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, for solution - Oral, Kit, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Lozenge - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Powder, Powder - Oral, Liquid; Tablet - Oral; Parenteral, Liquid; Tablet, Oral; Parenteral, Intramuscular; Intravenous; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet, Kit; Tablet - Oral, Kit; Powder, Kit; Powder - Oral, Topical, Liquid - Topical, Kit; Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Kit - Oral, Kit; Powder, for solution, Solution / drops, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets
Productive cough
, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL
, Liquid - Oral, Oral, Tablet, Liquid, Solution - Oral, Tablet - Oral, Syrup - Oral, Syrup, Tablet, coated, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Granule, effervescent - Oral, Powder, for solution, Capsule, liquid filled, Granule, effervescent, Capsule, liquid filled - Oral, Capsule, Capsule - Oral, Solution, Tablet, extended release - Oral, Tablet, extended release, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, for solution - Oral, Kit, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Lozenge - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Powder, Powder - Oral, Liquid; Tablet - Oral; Parenteral, Liquid; Tablet, Oral; Parenteral, Intramuscular; Intravenous; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet, Kit; Tablet - Oral, Kit; Powder, Kit; Powder - Oral, Topical, Liquid - Topical, Kit; Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Kit - Oral, Kit; Powder, for solution, Solution / drops, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets
Fever
, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL
, Liquid - Oral, Oral, Tablet, Liquid, Solution - Oral, Tablet - Oral, Syrup - Oral, Syrup, Tablet, coated, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Granule, effervescent - Oral, Powder, for solution, Capsule, liquid filled, Granule, effervescent, Capsule, liquid filled - Oral, Capsule, Capsule - Oral, Solution, Tablet, extended release - Oral, Tablet, extended release, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, for solution - Oral, Kit, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Lozenge - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Powder, Powder - Oral, Liquid; Tablet - Oral; Parenteral, Liquid; Tablet, Oral; Parenteral, Intramuscular; Intravenous; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet, Kit; Tablet - Oral, Kit; Powder, Kit; Powder - Oral, Topical, Liquid - Topical, Kit; Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Kit - Oral, Kit; Powder, for solution, Solution / drops, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets
Rhinitis, Allergic
, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL
, Liquid - Oral, Oral, Tablet, Liquid, Solution - Oral, Tablet - Oral, Syrup - Oral, Syrup, Tablet, coated, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Granule, effervescent - Oral, Powder, for solution, Capsule, liquid filled, Granule, effervescent, Capsule, liquid filled - Oral, Capsule, Capsule - Oral, Solution, Tablet, extended release - Oral, Tablet, extended release, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, for solution - Oral, Kit, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Lozenge - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Powder, Powder - Oral, Liquid; Tablet - Oral; Parenteral, Liquid; Tablet, Oral; Parenteral, Intramuscular; Intravenous; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet, Kit; Tablet - Oral, Kit; Powder, Kit; Powder - Oral, Topical, Liquid - Topical, Kit; Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Kit - Oral, Kit; Powder, for solution, Solution / drops, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets
Delayed Hypersensitivity
, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL
, Liquid - Oral, Oral, Tablet, Liquid, Solution - Oral, Tablet - Oral, Syrup - Oral, Syrup, Tablet, coated, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Granule, effervescent - Oral, Powder, for solution, Capsule, liquid filled, Granule, effervescent, Capsule, liquid filled - Oral, Capsule, Capsule - Oral, Solution, Tablet, extended release - Oral, Tablet, extended release, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, for solution - Oral, Kit, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Lozenge - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Powder, Powder - Oral, Liquid; Tablet - Oral; Parenteral, Liquid; Tablet, Oral; Parenteral, Intramuscular; Intravenous; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet, Kit; Tablet - Oral, Kit; Powder, Kit; Powder - Oral, Topical, Liquid - Topical, Kit; Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Kit - Oral, Kit; Powder, for solution, Solution / drops, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets
Influenza
, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL
, Liquid - Oral, Oral, Tablet, Liquid, Solution - Oral, Tablet - Oral, Syrup - Oral, Syrup, Tablet, coated, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Granule, effervescent - Oral, Powder, for solution, Capsule, liquid filled, Granule, effervescent, Capsule, liquid filled - Oral, Capsule, Capsule - Oral, Solution, Tablet, extended release - Oral, Tablet, extended release, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, for solution - Oral, Kit, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Lozenge - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Powder, Powder - Oral, Liquid; Tablet - Oral; Parenteral, Liquid; Tablet, Oral; Parenteral, Intramuscular; Intravenous; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet, Kit; Tablet - Oral, Kit; Powder, Kit; Powder - Oral, Topical, Liquid - Topical, Kit; Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Kit - Oral, Kit; Powder, for solution, Solution / drops, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets
Respiratory Tract Infections
, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL
, Liquid - Oral, Oral, Tablet, Liquid, Solution - Oral, Tablet - Oral, Syrup - Oral, Syrup, Tablet, coated, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Granule, effervescent - Oral, Powder, for solution, Capsule, liquid filled, Granule, effervescent, Capsule, liquid filled - Oral, Capsule, Capsule - Oral, Solution, Tablet, extended release - Oral, Tablet, extended release, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, for solution - Oral, Kit, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Lozenge - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Powder, Powder - Oral, Liquid; Tablet - Oral; Parenteral, Liquid; Tablet, Oral; Parenteral, Intramuscular; Intravenous; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet, Kit; Tablet - Oral, Kit; Powder, Kit; Powder - Oral, Topical, Liquid - Topical, Kit; Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Kit - Oral, Kit; Powder, for solution, Solution / drops, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets
Rhinitis, Vasomotor
, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL
, Liquid - Oral, Oral, Tablet, Liquid, Solution - Oral, Tablet - Oral, Syrup - Oral, Syrup, Tablet, coated, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Granule, effervescent - Oral, Powder, for solution, Capsule, liquid filled, Granule, effervescent, Capsule, liquid filled - Oral, Capsule, Capsule - Oral, Solution, Tablet, extended release - Oral, Tablet, extended release, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, for solution - Oral, Kit, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Lozenge - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Powder, Powder - Oral, Liquid; Tablet - Oral; Parenteral, Liquid; Tablet, Oral; Parenteral, Intramuscular; Intravenous; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet, Kit; Tablet - Oral, Kit; Powder, Kit; Powder - Oral, Topical, Liquid - Topical, Kit; Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Kit - Oral, Kit; Powder, for solution, Solution / drops, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets
Asthma
, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL
, Liquid - Oral, Oral, Tablet, Liquid, Solution - Oral, Tablet - Oral, Syrup - Oral, Syrup, Tablet, coated, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Granule, effervescent - Oral, Powder, for solution, Capsule, liquid filled, Granule, effervescent, Capsule, liquid filled - Oral, Capsule, Capsule - Oral, Solution, Tablet, extended release - Oral, Tablet, extended release, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, for solution - Oral, Kit, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Lozenge - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Powder, Powder - Oral, Liquid; Tablet - Oral; Parenteral, Liquid; Tablet, Oral; Parenteral, Intramuscular; Intravenous; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet, Kit; Tablet - Oral, Kit; Powder, Kit; Powder - Oral, Topical, Liquid - Topical, Kit; Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Kit - Oral, Kit; Powder, for solution, Solution / drops, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets
Food Hypersensitivity
, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL
, Liquid - Oral, Oral, Tablet, Liquid, Solution - Oral, Tablet - Oral, Syrup - Oral, Syrup, Tablet, coated, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Granule, effervescent - Oral, Powder, for solution, Capsule, liquid filled, Granule, effervescent, Capsule, liquid filled - Oral, Capsule, Capsule - Oral, Solution, Tablet, extended release - Oral, Tablet, extended release, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, for solution - Oral, Kit, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Lozenge - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Powder, Powder - Oral, Liquid; Tablet - Oral; Parenteral, Liquid; Tablet, Oral; Parenteral, Intramuscular; Intravenous; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet, Kit; Tablet - Oral, Kit; Powder, Kit; Powder - Oral, Topical, Liquid - Topical, Kit; Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Kit - Oral, Kit; Powder, for solution, Solution / drops, Solution / drops - Oral, Solution / drops - Nasal, Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets

Warnings

Tussicaps has twenty-one restrictions. It should not be taken in combination with any of the circumstances detailed in the following table.There are 20 known major drug interactions with Tussicaps.
Common Tussicaps Drug Interactions
Drug Name
Risk Level
Description
Amoxapine
Major
The metabolism of Amoxapine can be decreased when combined with Chlorpheniramine.
Anagrelide
Major
The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Anagrelide.
Arsenic trioxide
Major
The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Arsenic trioxide.
Artemether
Major
The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Artemether.
Asenapine
Major
The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Asenapine.
Tussicaps Toxicity & Overdose RiskTaking too much hydrocodone can lead to serious symptoms such as breathing problems, sleepiness, lack of muscle movement, cold and clammy skin, small pupils, fluid in the lungs, slow heartbeat, low blood pressure, or even death. To respond to an overdose, a person must be given oxygen and possibly assisted ventilation. Other treatments may include IV fluids, oxygen, and medication to raise blood pressure. Emergency medical help should be called if the person experiences cardiac arrest or an irregular heartbeat. A medication called naloxone can be administered to reverse the effects of the overdose, but medical attention is still necessary as the effects of
image of a doctor in a lab doing drug, clinical research

Tussicaps Novel Uses: Which Conditions Have a Clinical Trial Featuring Tussicaps?

50 active clinical trials are currently being conducted to investigate the potential of Tussicaps to alleviate Chronic Pain, Nasal Congestion stemming from the Common Cold and Acute Bronchitis.
Condition
Clinical Trials
Trial Phases
Asthma
92 Actively Recruiting
Phase 1, Phase 4, Early Phase 1, Phase 2, Not Applicable, Phase 3
Transfusion Reaction
0 Actively Recruiting
Pink Eye
0 Actively Recruiting
Nasal Congestion
0 Actively Recruiting
Hypersensitivity
1 Actively Recruiting
Phase 4
Headache
0 Actively Recruiting
Migraine
51 Actively Recruiting
Phase 4, Not Applicable, Phase 1, Phase 3, Phase 2, Early Phase 1
ocular hyperemia
0 Actively Recruiting
Influenza
0 Actively Recruiting
Conjunctivitis
0 Actively Recruiting
Coughing
0 Actively Recruiting
Airway secretion clearance therapy
0 Actively Recruiting
Nose
0 Actively Recruiting
Allergy to vaccine
0 Actively Recruiting
Angioedema
0 Actively Recruiting
Rhinorrhea
0 Actively Recruiting
Seasonal Allergic Conjunctivitis
0 Actively Recruiting
Cold
0 Actively Recruiting
Lacrimal Apparatus Diseases
0 Actively Recruiting
Coughing
0 Actively Recruiting

Tussicaps Reviews: What are patients saying about Tussicaps?

5Patient Review
12/27/2009
Tussicaps for Cough
I really liked this cough suppressant! I was hesitant to try a pill, but it worked great. No nasty taste or mess like with syrup, and it made me feel relaxed and happy without being too drowsy.
5Patient Review
12/15/2009
Tussicaps for Cough
I was worried that, at $4 a pill, these wouldn't work. But I was amazed--they were awesome. After a month of suffering with a sinus and upper respiratory infection that wouldn't go away, this stopped the cough the others couldn't. My chest felt like i had been beaten up until i took them. All I can say is wow and thank you!
5Patient Review
12/4/2009
Tussicaps for Cough
I would not recommend this medication to anyone. I had a terrible experience with it and suffered through restless nights, vomiting, dizziness, and headaches.
5Patient Review
1/20/2010
Tussicaps for Cough
I was in a lot of pain from coughing for four days straight before I tried this treatment. Within just a few hours, the cough began to subside and within six hours it had almost completely stopped. And on top of that, the pain was gone too!
5Patient Review
12/14/2010
Tussicaps for Cough
This is an effective treatment, and worth the price tag.
5Patient Review
3/20/2010
Tussicaps for Cough
Though this treatment effectively got rid of my cough, the side effects were not worth it. I felt nauseous and dizzy for an entire day after just one dose.
5Patient Review
1/13/2015
Tussicaps for Cough
Tussicaps, used in conjunction with an antibiotic, cleared up my respiratory infection and cough very effectively. I'm now able to go back to work without any issues.
5Patient Review
10/29/2009
Tussicaps for Cough
5Patient Review
4/28/2012
Tussicaps for Cold Symptoms
I had a severe reaction to this medication a few hours after taking only one capsule. I was administered Benedryl (maximum dose) three times during the day, and I'm still having some reactions 24 hours later, although they are not as severe. I contacted the company to determine which ingredient most likely caused this effect so that I can avoid it in the future. This has been very scary for me, with large welts that look almost like blisters, and are very red and itchy.
4.7Patient Review
12/18/2009
Tussicaps for Cough
This medicine was very effective at suppressing my cough and stopping the burning pain in my chest. The drowsiness it caused was a bit of an issue, but since I was already out of work sick, it wasn't really a problem for me.
4.3Patient Review
11/6/2009
Tussicaps for Cough
While this treatment didn't stop my coughing at all, it did help me get through the bronchitis a bit easier.
3.7Patient Review
5/7/2011
Tussicaps for Cold Symptoms
Tussicaps are a great option for those with an upper respiratory issue. They work quickly and last for several hours. The only downside is that they can cause lightheadedness if taken on an empty stomach, but it's a small price to pay for the relief they provide.
3Patient Review
1/6/2010
Tussicaps for Cough
I was never aware of this medication until my doctor prescribed it for me. It's been really helpful in reducing my cough reflex.
2.3Patient Review
10/7/2009
Tussicaps for Cough
2.3Patient Review
10/28/2009
Tussicaps for Cough
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about tussicaps

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the drug tussionex?

"TUSSIONEX Pennkinetic Extended-Release Suspension is a prescription medicine used to treat cough and upper respiratory symptoms that you can have with allergies or a cold. TUSSIONEX Pennkinetic Extended-Release Suspension is for adults and children aged 6 years and older."

Answered by AI

What is Deconamine used for?

"Decongestants help to reduce swelling in the nasal passages.

This medication is a combination of an antihistamine and a decongestant and is used to relieve symptoms of the common cold, flu, allergies, or other breathing illnesses temporarily. Antihistamines help relieve watery eyes, itchy eyes/nose/throat, runny nose, and sneezing while decongestants help reduce swelling in the nasal passages."

Answered by AI

What are TussiCaps used for?

"- The FDA has approved TussiCaps (acetaminophen, dextromethorphan, guaifenesin, and phenylephrine) oral suspension, the first fixed-dose combination of these four drugs in a single product.

TussiCaps has been approved by the FDA to treat runny nose, sneezing, itching, watery eyes, and cough caused by allergies, the common cold, or the flu. This is the first fixed-dose combination of these four drugs in a single product."

Answered by AI

Clinical Trials for Tussicaps

Image of Johns Hopkins Medicine in Baltimore, United States.

Embolization for Migraine

18 - 80
All Sexes
Baltimore, MD
This study is to test the safety and feasibility of a procedure called embolization of the middle meningeal arteries (MMA), using a product called Onyx. Embolization creates a plug in the arteries. MMA embolization with Onyx is not approved for use in patients with migraines, but is currently used in patients with subdural hematomas. The FDA is allowing the use of Onyx in this study. It is thought that by using Onyx to block the middle meningeal arteries, the amount of migraine-causing substances which are released into the brain's bloodstream will be reduced. The company that manufactures Onyx, Medtronic, is providing the supplies for this study. Participants will be in the study for about 8 months after enrolling, including 6 months of follow up after the procedure. The participants will be asked to complete a daily headache diary and continue the participant's regular migraine medications. Participants will also have several clinic visits and be asked to provide blood samples for research.
Waitlist Available
Has No Placebo
Johns Hopkins MedicineRisheng Xu, MD, PhDMedtronic
Have you considered Tussicaps clinical trials? We made a collection of clinical trials featuring Tussicaps, we think they might fit your search criteria.Go to Trials
Image of Vanderbilt University Medical Center in Nashville, United States.

High vs. Standard Dose Influenza Vaccines for Flu

18+
All Sexes
Nashville, TN
This will be a follow-up study to the "Comparison of High Dose vs. Standard Dose Influenza Vaccine in Lung Allograft Recipient" study (DMID Protocol Number 22-0014) at Vanderbilt University Medical Center. Lung transplantation is a life-saving therapy for patients with advanced lung disease, and is also associated with an improvement in quality of life. However, due to the need for life-long immunosuppression to prevent acute cellular rejection and chronic lung allograft dysfunction ("chronic rejection"), lung transplant recipients are at risk for developing major infections. In fact, one-year survival is 85%, with infection being the leading cause of death within the first year post-transplant. We will conduct a follow-up phase II, randomized, double-blind trial to assess the impact of subsequent administration of two doses of HD-IIV compared to two doses of SD-IIV among lung recipients during the early post-transplant period. Demonstration of improved immunogenicity from two doses of HD-IIV over consecutive influenza seasons would provide potential broad benefit in reducing influenza disease and its associated complications in lung transplant recipients. Moreover, studying vaccine immunogenicity and safety in the same participants over consecutive years can provide insight into the influence of immunosuppression levels and allograft aging on vaccine-mediated immune modulation. This proposed study design will contribute significantly to influenza vaccination guidance and policy for the highly vulnerable lung transplant population. This proposed study is designed to address several key knowledge gaps in vaccine-mediated protection of lung transplant recipients against influenza: * Is there increased immunogenicity with administration of one or two doses of HD-IIV or SD-IIV in the subsequent season compared to two doses of HD-IIV or SD-IIV in the first season? * What is the durability of the humoral and cellular immune response between influenza seasons and does two doses of HD-IIV or SD-IIV sustain higher HAI titers compared to two doses of HD-IIV or SD-IIV in the first season? * What is the impact of maintenance immunosuppression levels on influenza vaccine immunogenicity within the same participant? * Will the optimal immunogenic vaccination strategy be associated with an acceptable long-term safety profile over successive influenza seasons, including injection-site and systemic reactions, allosensitization, and organ rejection?
Phase 2
Recruiting
Vanderbilt University Medical CenterNatahsa Halasa, MD, MPH
Image of Altasciences Inc - Kansas City in Overland Park, United States.

VNT-101 for Safety and Tolerability Study

18 - 59
All Sexes
Overland Park, KS
A randomized, double-blind, placebo-controlled Phase 1 study conducted at a single center with approximately 78 healthy adults aged 18-59 years. Part 1 Single Ascending Dose (SAD) will enroll 48 participants into six cohorts (S1-S6) to receive single oral doses of VNT-101 (100-1500 mg) or placebo under fasting or fed (S5 only) conditions. Part 2 Multiple Ascending Dose (MAD) will enroll 30 participants into three cohorts (M1-M3) to receive multiple oral doses of VNT-101 (250-750 mg BID Days 1-5, QD Day 6) or placebo under fasting conditions. Dose escalation in both parts will proceed after Protocol Safety Review Team (PSRT) review. The primary objective for Part 1 is to evaluate the safety and tolerability of single ascending oral (SAD) doses of VNT-101 in healthy adult participants under either fasting or fed conditions. The primary objective for part 2 is to evaluate the safety and tolerability of multiple ascending oral (MAD) doses of VNT-101 in healthy adult participants.
Phase 1
Recruiting
Altasciences Inc - Kansas City
Have you considered Tussicaps clinical trials? We made a collection of clinical trials featuring Tussicaps, we think they might fit your search criteria.Go to Trials
Image of University of the Fraser Valley in Chilliwack, Canada.

Mind-Body App + Movement Program for Chronic Pain

19 - 75
All Sexes
Chilliwack, Canada
The investigators are evaluating the effects of a mind-body mobile application, in combination with a guided movement program, on the experience of chronic pain. Participants meeting the criteria for chronic/persistent pain (confirmed via self-report) will complete an online baseline questionnaire. Eligible participants will take part in an intervention that involves use of a 6-week free trial of a mind-body focused mobile application in combination with virtual asynchronous audio-guided somatic education sessions (gentle movement). External data from a usual care control arm and a mobile-app-only arm from a previous study by the same research team, National Clinical Trials (NCT) registry number NCT05090683, will be used for comparison with the current combined intervention. All participants will complete online surveys at the start of the study and after 6 weeks to measure pain intensity and interference (primary outcomes), mental health outcomes (depression, anxiety, stress), pain-related thoughts (pain catastrophizing), quality of life, and fear of movement (secondary outcomes). From weeks 2 to 6, participants will fill out weekly surveys to track how often they engage with each: the somatic education (gentle movement) program and the mobile app. Participants will also complete a follow-up survey at 12 weeks (6 weeks post-intervention conclusion).
Waitlist Available
Has No Placebo
University of the Fraser ValleyCynthia J Thomson, PhD
Image of Miami Valley Hospital in Dayton, United States.

Intranasal Nerve Block for Headache

18+
All Sexes
Dayton, OH
In patients with bleeding from a brain aneurysm, severe headache is the most common complaint. However, the pain is difficult to treat. The use of standard pain medications is common, but pain control remains poor. Additionally, pain medicines have multiple side effects including sedation, interference with breathing, intestinal cramping, low blood pressure, and the risk of addiction. In the present study, the investigators will examine the use of a medication to block the sphenopalatine ganglion which is a bundle of nerves that includes nerves that cause head pain. This block is performed by spraying numbing medication into the back of the nasal cavity on both sides. This particular pain medication does not have the side effects discussed above. The purpose of the study is to see if this treatment will decrease pain without causing unwanted side effects. All patients in the study will receive standard pain medicine as needed for headache. Information will be collected from the patient's medical chart on the amount of pain medication used and the amount of pain the patient describes having. The average pain will be calculated for the first 24 hours the patient is in the hospital. At that point, the patient will receive pain medication sprayed into the back of the nasal cavity on both sides. Patients will also receive this treatment 3 days later. Following these treatments, information will be obtained on the average amount of pain, and how much other pain medication is used. The investigators will look at the amount of pain and the amount of other pain medicine used over the first 24 hours before the nasal pain medicine treatment and compare it to the time after the treatments to see if the amount of pain decreases and if the amount of other pain medicine needed decreases as well. Six months after discharge, the patient will be contacted by phone to find out more information about how much head pain they had after discharge from the hospital.
Phase 4
Recruiting
Miami Valley Hospital
Image of University of Maryland, School of Medicine, Center for Vaccine Development and Global Health in Baltimore, United States.

pH1N1 Virus for Flu

18 - 55
All Sexes
Baltimore, MD
This protocol describes a clinical trial to develop and validate a Controlled Human Infection Model (CHIM) for influenza A/Arkansas/08/2020 (pH1N1). The study is designed to determine the optimal infectious dose of the pH1N1 challenge strain for use in future clinical trials evaluating influenza countermeasures. The study will enroll and challenge adult volunteers with the pH1N1 influenza virus challenge or sham inoculations. Given the adaptive design of this trial, the potential number of participants can vary. Depending on the pathway recommended by the PSRT and followed in the Trial Schema, the study population can range from around 30 to 120. However, it is anticipated that the final sample size will be around 60 participants receiving pH1N1 challenge product plus approximately 4 persons receiving a sham inoculation. Participants will be pre-screened for health and for serological HAI antibody titers of \</1:40 against the challenge strain. Eligible participants will be enrolled sequentially into challenge cohorts and will be randomly assigned to receive a single dose of either sham inoculation or the interventional study product at a dose between 10\^6 to 10\^7 TCID50 (or 10\^5 TCID50 if needed). Dose titration will be conducted under an adaptive escalation schedule whereby dosing will start at 10\^6 TCID50 and escalate to the next dose if a pre-determined symptomatic influenza attack rate and clinical symptom score thresholds are not met and if the dose is determined to be safe with no pre-defined halting criteria being met. The primary objectives of this study are to determine the optimal infectious dose of a pH1N1 viral challenge to cause laboratory-confirmed clinical influenza and to assess the safety profile of pH1N1 viral challenge.
Phase 1
Recruiting
University of Maryland, School of Medicine, Center for Vaccine Development and Global Health (+1 Sites)
Have you considered Tussicaps clinical trials? We made a collection of clinical trials featuring Tussicaps, we think they might fit your search criteria.Go to Trials
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security